Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 14, No. 4, 2005
Issue release date: July – August
Section title: Case Report
Open Access Gateway
Med Princ Pract 2005;14:281–283

Late Development of Diabetes mellitus after Interferon-Alfa and Ribavirin Therapy for Chronic Hepatitis C: A Case Report

Radhakrishnan S.a · Upadhyay A.a · Mohan N.a · Dhar A.a · Walia H.a · Zubaidi G.b
Departments of aGastroenterology and bEndocrinology, The Royal Hospital, Muscat, Oman
email Corresponding Author

Dr. S. Radhakrishnan, FRCP (Edin)

Gastroenterology Division

The Royal Hospital, PO Box 1331, CPO 111

Muscat (Oman)

Tel./Fax +968 594461, E-Mail jagan01@omantel.net.om


  1. Cohen J: The scientific challenge of hepatitis C. Science 1999;285:26–30.
  2. Allison MED, Wreghitt T, Palmer CR, Alexander GJM: Evidence of a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994;21:1135–1139.
  3. Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo U, Petrik J, et al: Further evidence for an association between non-insulin dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999;30:1059–1063.
  4. Mehta SH, Brancati GL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL: Prevalence of type-2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000;133:592–599.
  5. Fabris P, Betterle C, Greggio NA, Zanchetta R, Bosi E, Biasin MR, et al: Insulin-dependent diabetes mellitus during alfa-interferon therapy for chronic viral hepatitis. J Hepatol 1998;28:514–517.
  6. Uto H, Matsuoka H, Murata M, Okamoto T, Miyata Y, Hori T, et al: A case of chronic hepatitis C developing insulin-dependent diabetes mellitus associated with various autoantibodies during interferon therapy. Diabetes Res Clin Pract 2000;49:101–106.
  7. Recasens M, Aguilera E, Ampurdanes S, Sanches Tapias JM, Simo O, Casamitjana R, et al: Abrupt onset of diabetes during interferon-alpha therapy in patients with chronic hepatitis C. Diabet Med 2001;18:764–767.
  8. Eibl N, Gschwantler, Ferenci P, Eibl MM, Weiss W, Schernthaner G: Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha. Eur J Gastroenterol Hepatol 2001;13:295–298.
  9. Wasmuth HE, Stolte C, Geier A, Gartung C, Matern S: Induction of multiple autoantibodies to islet cell antigens during treatment with interferon alfa for chronic hepatitis C. Gut 2001;49:596–597.
  10. Dicesare E: Interferon-alpha therapy may induce insulin autoantibody development in patients with chronic viral hepatitis. Dig Dis Sci 1996;41:1672–1677.
  11. McLaren NK, Lan M, Coutant R, et al: Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2 predict immune-mediated (type-I) diabetes in relatives. J Autoimmun 1999;12:279–287.
  12. Bhatti A, McGarrity TJ, Gabbay R: Diabetic ketoacidosis induced by alfa interferon and ribavirin treatment in a patient with hepatitis C. Am J Gastroenterol 2001;96:604–605.